Nederland
Interactieve versie
U vindt veel meer informatie per bedrijf en veel meer bedrijven. Ook kunt u filters toepassen en exporteren naar Excel.
AM-Pharma B.V.
Utrecht - Utrecht
www.am-pharma.com
Naam
AM-Pharma B.V.
Sector
Vervaardiging van farmaceutische producten
Werkenden
10-49 wn.
Adres
Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.
Postcode
3521AZ
Plaatsnaam
Utrecht
-147 -3 -5 -78 /10.1093/jbmr/zjaf023 /aacb-19-00031 /asbmr/2025/meetingapp.cgi/paper/5008 /fendo.2023.1138599 /j.1469-1809.2011.00644.x /j.bone.2013.01.024 /j.bone.2014.11.017 /j.bone.2020.115664 /j.metabol.2016.07.006 /j.metabol.2017.08.013 /jbmr.4130 /jbmr/zjaf141 /jbmr/zjaf185 /jci117874 /nrendo.2016.14 /s00198-017-4091-y /s00198-020-05760-y /s13023-022-02420-3 0 1 10 10.1002 10.1007 10.1016 10.1038 10.1093 10.1111 10.1172 10.1186 10.33176 10.3389 100 1000 1020 11 1138599 115664 11th 12 13 137 14 142 1440 1445 147 1522 1530 155 16th 17 190 1995 1b 2 2.5 200 2002 2011 2013 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 20th 21 2171 2178 233 246 24th 2505 2513 2653 2662 26th 27 277 27th 28 2nd 3 32 35 4 41 41055578 439 445 5 50.1 54 5th 65 68 7 72 75 82 9 95 a abl about abov abstract accept accessed accountability accountabl achiev acquisition act action activ activity acut addition additionally address adjust administered administration adult adulthod advanc advisor aetiology affected against aged agred ahead alfa alkalin all alleviated alpl also altmeyer am am-pharma america american an analysis and and/or angelini animal ann announces annual approach are arvell as asbmr asbmr.confex.com asbmr.confex.com/asbmr/2025/meetingapp.cgi/paper/5008 asfotas aspect asset associated at avenues axovant b b.v ba backed background based be befor being benefit berg berkseth bernholz beyond billion biochem biochemical biological biomarker bl board body bon bone-target bones bouy bring bristol bristol-myer bttr building built burd busines but by can capabilities capital car cardiac carer cartilag centr ceo cetus chairman characteristic chief chimeric chondrocalcinosis chronic circulat clear cleav clin clinical collaboration collaborativ collect colleg commercial committed common company completes complication compound compromised concept concern condition confronted consequences considerabl consistent constraint constructiv contain continually contribut control convenient
Vind meer informatie over AM-Pharma B.V. in de interactieve versie